Does Adriamycin cause heart failure?
- Yes. There is a risk of people developing cardiotoxicity including heart failure with Adriamycin use
- The risk increases as the cumulative dose of Adriamycin increases
- The probability of developing congestive heart failure ranges from 1.5% for a cumulative dose of 300 mg/m2 of Adriamycin up to 20.5-21% for a cumulative dose of 500-728 mg/m2 of Adriamycin
- The risk is higher if Adriamycin is used with other chemotherapy agents, such as cyclophosphamide, fluorouracil, or vincristine
- Cardiotoxicity including heart failure is also more likely to occur in seniors, people exposed to Adriamycin at a young age, concomitant use of other cardiotoxic drugs, calcium channel blockers, pre-existing heart disease, or prior radiation therapy to the heart
- People prescribed the monoclonal antibody trastuzumab have a much higher risk of cardiotoxicity including heart failure with Adriamycin at lower cumulative doses.
Cardiotoxicity is one of the most common potential long-term side effects of Adriamycin.
Cardiotoxicity means permanent damage to the muscles of the heart or the functioning of the heart. Cardiotoxicity can be severe with Adriamycin treatment and may develop late during therapy, or within two to three months after the treatment has ended.
Symptoms include signs or symptoms of heart failure, including a reduced ability of the left side of the heart to pump (called LVEF or left ventricular ejection fraction), a fast heartbeat, shortness of breath, fluid on the lungs, as well as other related symptoms.
The probability of developing cardiotoxicity increases the higher the cumulative dose of Adriamycin that has been given, for example, the probability is:
- 1-2% for a total cumulative dose of 300 mg/m2 of Adriamycin
- 3-5% for a total cumulative dose of 400 mg/m2 of Adriamycin
- 5-8% for a total cumulative dose of 450 mg/m2 of Adriamycin
- 6-20% for a total cumulative dose of 500 mg/m2 of Adriamycin.
The probability of developing congestive heart failure has been reported as:
- 1.5% for a cumulative dose of 300 mg/m2 of Adriamycin
- 3-4.9% for a cumulative dose of 400-430 mg/m2 of Adriamycin
- 7-7.7% for a cumulative dose of 450-475 mg/m2 of Adriamycin
- 20.5-21% for a cumulative dose of 500-728 mg/m2 of Adriamycin.
The risk of developing heart failure rapidly increases with increasing cumulative doses above 400 mg/m2 and when Adriamycin is used with other chemotherapy agents, such as cyclophosphamide, fluorouracil, or vincristine.
Cardiotoxicity may also occur at lower doses in seniors, people exposed to Adriamycin at a young age, concomitant use of other cardiotoxic drugs, calcium channel blockers, pre-existing heart disease, or prior radiation therapy to the heart.
People prescribed the monoclonal antibody trastuzumab have a much higher risk of cardiotoxicity with Adriamycin at lower cumulative doses.
The package insert for Adriamycin states that lifetime cumulative doses above 550 mg/m2 (21-day cycles) are associated with an increased risk of cardiomyopathy.
In people at higher risk of cardiotoxicity, the maximum cumulative dose of doxorubicin should be limited to less than 400 mg/m2.
In certain cases, people who have received total cumulative doses of 450 mg/m2 may be considered for further therapy up to a total cumulative dose of 700 mg/m2 provided they undergo cardiac assessment and are deemed to be suitable to continue treatment.
Dexrazoxane may be used for cardioprotection in patients with advanced or metastatic cancer who are at risk of developing cardiotoxicity when receiving Adriamycin.
Related questions
References
- Adriamycin (doxorubicin) for injection. FDA https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/062921s022lbl.pdf
- Doxorubicin (Rx) Medscape.com https://reference.medscape.com/drug/doxorubicin-342120
- Rahman AM, Yusuf SW, Ewer MS. Anthracycline-induced cardiotoxicity and the cardiac-sparing effect of liposomal formulation. Int J Nanomedicine. 2007;2(4):567–583.
- Doxorubicin. Drugs.com Oct 7 2019. https://www.drugs.com/dosage/doxorubicin.html
Read next
How to increase ejection fraction naturally?
Lifestyle measures that can help improve your ejection fraction naturally, in addition to medications and other measures prescribed by your doctor, include doing moderate-intensity physical activity at least 3 to 5 times per week for at least 20 to 40 minutes per session, avoiding substances that can affect your heart or worsen your symptoms such as alcohol, cocaine, methamphetamines, stimulants, and cigarettes, limiting how much salt you eat to no more than 1,500 to 2,000 milligrams per day, manage your stress with relaxation exercises, meditation, yoga, and deep breathing. Continue reading
How can you check for heart disease at home?
You can check for heart disease at home by measuring your pulse rate and your blood pressure if you have a blood pressure monitor. To measure your pulse you will need an analog watch (one with a clock face rather than digital numbers) with a second hand. Place your index and middle finger of your hand on the hollow part of your inner wrist of the other arm, just below the base of the thumb. You should feel a tapping or pulse against your fingers, that is your heartbeat. Look at your watch and count the number of taps you feel in 10 seconds. Multiply that number by 6 to find out your heart rate for 1 minute. Continue reading
Metoprolol Succinate vs Tartrate: What's the difference between them?
Metoprolol is available as two different salts: metoprolol tartrate and metoprolol succinate.
The main difference between metoprolol tartrate and metoprolol succinate is that metoprolol tartrate is only available as an immediate-release tablet which means it must be taken several times per day, whereas metoprolol succinate is an extended-release tablet that can be taken once a day. As a result, there are differences in the dosages and indications for both metoprolol tartrate and metoprolol succinate and they are not considered interchangeable. Continue reading
Related medical questions
- What is the lifetime or cumulative dose for Adriamycin?
- How does AC (Adriamycin and Cytoxan [cyclophosphamide]) work for Breast Cancer?
- What are the long-term side effects of Adriamycin?
- Can I take ibuprofen with blood pressure medications?
- Does metoprolol lower resting heart rate?
- What are the equivalent dosages of bumetanide, furosemide & torsemide?
- Should you drink a lot of water when taking Lasix?
- Losartan vs Valsartan - What's the difference between them?
- Which drugs increase ejection fraction?
- What is the normal ejection fraction of the heart?
- How much does Entresto cost per month?
- What is the antidote for warfarin?
- Can Jardiance cause kidney problems?
- Does walking/exercise improve ejection fraction?
- Is Entresto a blood thinner and does it lower blood pressure?
- Does Farxiga cause weight loss?
- How long does it take for Farxiga to work?
- Can Farxiga cause kidney damage?
- How is atenolol superior to metoprolol?
- How does Jardiance help with heart failure?
- What is Farxiga used for and how does it work?
- Can Zepbound and Mounjaro be used for heart failure?
- Can Farxiga cause constipation?
- Why does warfarin cause purple toe syndrome?
- Can Wegovy or Ozempic be used for heart failure?
- Why are Warfarin tablets color-coded?
- How do you know if you have heart disease?
- Does COVID-19 cause heart injury?
- What is the strength of CaroSpir (spironolactone) oral suspension?
Drug information
Related support groups
- Doxorubicin (7 questions, 10 members)
- Adriamycin (5 questions, 8 members)
- Heart Failure (75 questions, 166 members)